Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Other Accumulated Expenses (2018 - 2025)

AdaptHealth (AHCO) has 8 years of Other Accumulated Expenses data on record, last reported at $30.1 million in Q4 2025.

  • For Q4 2025, Other Accumulated Expenses rose 13.59% year-over-year to $30.1 million; the TTM value through Dec 2025 reached $30.1 million, up 13.59%, while the annual FY2025 figure was $30.1 million, 13.59% up from the prior year.
  • Other Accumulated Expenses reached $30.1 million in Q4 2025 per AHCO's latest filing, up from $29.0 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $108.3 million in Q1 2021 and bottomed at $10.7 million in Q4 2023.
  • Average Other Accumulated Expenses over 5 years is $34.9 million, with a median of $27.9 million recorded in 2022.
  • Peak YoY movement for Other Accumulated Expenses: surged 557.86% in 2021, then crashed 65.27% in 2022.
  • A 5-year view of Other Accumulated Expenses shows it stood at $43.2 million in 2021, then crashed by 54.01% to $19.9 million in 2022, then crashed by 46.36% to $10.7 million in 2023, then skyrocketed by 148.78% to $26.5 million in 2024, then grew by 13.59% to $30.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Accumulated Expenses were $30.1 million in Q4 2025, $29.0 million in Q3 2025, and $28.9 million in Q2 2025.